Nicole Fer

Nicole Fer

UNVERIFIED PROFILE

Are you Nicole Fer?   Register this Author

Register author
Nicole Fer

Nicole Fer

Publications by authors named "Nicole Fer"

Are you Nicole Fer?   Register this Author

8Publications

214Reads

24Profile Views

Blockade of leukemia inhibitory factor as a therapeutic approach to KRAS driven pancreatic cancer.

Nat Commun 2019 07 11;10(1):3055. Epub 2019 Jul 11.

Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, 94158, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41467-019-11044-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6624260PMC
July 2019

Differential Effector Engagement by Oncogenic KRAS.

Cell Rep 2018 02;22(7):1889-1902

Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, 1450 3rd Street, San Francisco, CA 94158, USA; Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., P.O. Box B, Frederick, MD 21702, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.celrep.2018.01.051DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6343826PMC
February 2018

Small Cell Lung Cancer Screen of Oncology Drugs, Investigational Agents, and Gene and microRNA Expression.

J Natl Cancer Inst 2016 10 31;108(10). Epub 2016 May 31.

Affiliations of authors: Molecular Pharmacology Group, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD (DE, TS, RD, JL, CO, RR, MS, JC, EH, NF, AM); Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis (MK, GK, JM, BAT), Biometric Research Program, Division of Cancer Treatment and Diagnosis (EP, DS), and Cancer Therapy Evaluation Program (SM), National Cancer Institute, Rockville, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djw122DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6279282PMC
October 2016

Autocrine production of IL-11 mediates tumorigenicity in hypoxic cancer cells.

J Clin Invest 2013 Apr 15;123(4):1615-29. Epub 2013 Mar 15.

Developmental Therapeutics Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland 21702, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1172/JCI59623DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3613900PMC
April 2013

The HIF-1α-c-Myc pathway and tumorigenesis: evading the apoptotic gate-keeper.

Cell Cycle 2011 Oct 1;10(19):3228. Epub 2011 Oct 1.

National Cancer Institute, Frederick, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/cc.10.19.17049DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3356795PMC
October 2011

Adaphostin toxicity in a sensitive non-small cell lung cancer model is mediated through Nrf2 signaling and heme oxygenase 1.

J Exp Clin Cancer Res 2010 Jul 9;29:91. Epub 2010 Jul 9.

Laboratory of Functional Genomics, SAIC-Frederick Inc., NCI-Frederick, 1050 Boyles Street, Frederick, MD 21702, USA.

View Article

Download full-text PDF

Source
http://jeccr.biomedcentral.com/articles/10.1186/1756-9966-29
Publisher Site
http://dx.doi.org/10.1186/1756-9966-29-91DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2909968PMC
July 2010